[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364348-105":59,"doc-detail-364348-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","clinical-significance-and-pathogenic-mechanisms-of-long-non-coding-rna-trpm2-as-in-cancers","Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers","","Long non-coding RNAs (lncRNAs) are implicated in multiple human cancers, and TRPM2-AS is frequently elevated across cancer types. Higher TRPM2-AS levels correlate with key clinicopathological features, including tumor size, tumor stage, and lymph node metastasis, supporting its value for diagnosis, prognosis, and therapy. TRPM2-AS modulates proliferation, migration, invasion, apoptosis, and drug or radio-resistance through mechanisms such as competing endogenous RNA activity, protein binding, and regulation of signaling pathways. This review consolidates aberrant expression patterns, links to clinical characteristics, and detailed functional mechanisms across cancers, emphasizing TRPM2-AS as a prognostic and therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinical-significance-and-pathogenic-mechanisms-of-long-non-coding-rna-trpm2-as-in-cancers/364348/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinical-significance-and-pathogenic-mechanisms-of-long-non-coding-rna-trpm2-as-in-cancers/364348.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinicopathological features are associated with elevated TRPM2-AS in cancers?","Question",{"text":112,"@type":113},"Elevated TRPM2-AS is associated with tumor size, tumor stage, and lymph node metastasis, indicating links to disease severity and spread.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does TRPM2-AS influence cancer cell behaviors?",{"text":117,"@type":113},"TRPM2-AS regulates cell proliferation, migration, invasion, apoptosis, and drug or radio-resistance through multiple mechanisms including ceRNA activity, protein binding, and signaling pathway modulation.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the purpose of the review regarding TRPM2-AS?",{"text":121,"@type":113},"The review summarizes current knowledge on TRPM2-AS aberrant expression, its relationships with clinical features, and the detailed mechanisms underlying its potential functions across cancer types.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364348,1790319579,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Clinical Signiﬁcance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers  \nShichen Huang, MS 1,†, Bowen Li, MS 1,†, Huanyu Chen, MD2, Cheng Rong2, Zheng Yang, MD2, and Xianqin Zhang, PhD2   \nTechnology in Cancer Research & Treatment  \nVolume 24: 1-16  \n© The Author(s) 2025  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/15330338251315625](DOI: 10.1177/15330338251315625)[ ](DOI: 10.1177/15330338251315625)[journals.sagepub.com/home/tct](journals.sagepub.com/home/tct)  \nAbstract  \nLong non-coding RNAs (lncRNAs) are known to play vital roles in human cancers. LncRNA TRPM2-AS has been found to be upregulated in various types of cancers. The elevated levels of TRPM2-AS are associated with important clinicopathological parameters such as tumor size, tumor stage, and lymph node metastasis, revealing that TRPM2-AS could be a potential target for cancer diagnosis, prognosis and treatment. Moreover, TRPM2-AS is involved in regulating the cell proliferation, migration, invasion, apoptosis, drug or radio resistance by serving as a competing endogenous RNA, directly bounding to proteins and regulating multiple signaling pathways. In this review, we comprehensively summarize the latest knowledge on the aberrant expression of TRPM2-AS, the relationship between TRPM2-AS and clinical features, and the detailed mechanisms of potential functions of TRPM2-AS in various cancer types. The current study highlights the potential of TRPM2-AS as a prognostic and therapeutic target in cancers.  \nKeywords  \nlncRNA, TRPM2-AS, clinical application, molecular mechanism, ceRNA  \nReceived: October 5, 2024; Revised: December 12, 2024; Accepted: December 23, 2024.  \nBackground  \nThe malignant tumor is the main cause of human death. According to the latest Global Cancer Statistics, 1 there were approximate 20 million new cancer cases and about 9.7 million deaths in the year 2022 . Although cancer mortality continues to decline, there are still 22 . 8% cancer deaths from noncommunicable diseases worldwide. The prognosis for cancer remains poor, despite advancements in therapy methods. Therefore, further research on the mechanisms of tumorigenesis and progression is necessary to identify effective biomarkers and therapeutic targets, which can provide new strategies for early diagnosis, prognosis evaluation, and treatment of malignant tumors.  \nApproximately 90% of the human genome is transcribed, but only 2% is made up of protein-coding genes. Long non-coding RNAs (lncRNAs) are a diverse class of RNA molecules that exceed 200 nucleotides in length and lack a protein-coding ability.2 With the advancement of high throughout technologies and deeper scientiﬁc research, more and more lncRNAs have been identiﬁed as key players in a wide range of physiological  \nand pathological processes, including chromatin modiﬁcation, transcriptional regulation, and post-transcriptional regulation of proximal and distal genes.345–6 Due to the high efﬁciency, tissue speciﬁcity, and dynamic expression during development,7 lncRNAs exhibit potential as diagnostic, prognostic indicators, and therapeutic targets for tumors.  \n1 School of Clinical Medicine, Chengdu Medical College, 783 Xindu Avenue, Chengdu, 610500, Sichuan, China  \n2 School of Basic Medical Sciences, Chengdu Medical College, 783 Xindu Avenue, Chengdu, 610500, Sichuan, China  \n† These authors contributed equally to this work.  \nCorresponding Authors:  \nXianqin Zhang, School of Basic Medical Science, Chengdu Medical College, 783 Xindu Avenue, Chengdu, 610500, Sichuan, China.  \nEmail: [sclzzxq@hotmail.com](sclzzxq@hotmail.com)  \nZheng Yang, School of Basic Medical Science, Chengdu Medical College, 783 Xindu Avenue, Chengdu, Sichuan 610500, China.  \nEmail: [yzixjj@163.com](yzixjj@163.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-Non","cbCainSykyLPkdGB","https://ap.wps.com/l/cbCainSykyLPkdGB","pdf",2608176,16,"English","# Abstract\n# Background\n# Clinical Significance of TRPM2-AS in Cancers\n# Conclusion and Therapeutic Implications","[{\"question\":\"What clinicopathological features are associated with elevated TRPM2-AS in cancers?\",\"answer\":\"Elevated TRPM2-AS is associated with tumor size, tumor stage, and lymph node metastasis, indicating links to disease severity and spread.\"},{\"question\":\"How does TRPM2-AS influence cancer cell behaviors?\",\"answer\":\"TRPM2-AS regulates cell proliferation, migration, invasion, apoptosis, and drug or radio-resistance through multiple mechanisms including ceRNA activity, protein binding, and signaling pathway modulation.\"},{\"question\":\"What is the purpose of the review regarding TRPM2-AS?\",\"answer\":\"The review summarizes current knowledge on TRPM2-AS aberrant expression, its relationships with clinical features, and the detailed mechanisms underlying its potential functions across cancer types.\"}]","Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers | PDF",1790157141,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc9b4d0e2a7b3c8d233dae3300b5fcb3.webp",983,1276,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4838a16eba77d15296bc5011c57fccc2.webp",982,1275,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/801afa561a36e0b4b89405b60db978c3.webp",981,1273,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d8bd959e2f75e51476cf619f4c5fe9b.webp",980,1272]